{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:28:49Z","timestamp":1790004529418,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K01 AR075879"],"award-info":[{"award-number":["K01 AR075879"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K24 AR070892"],"award-info":[{"award-number":["K24 AR070892"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30 AR07257"],"award-info":[{"award-number":["P30 AR07257"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["RO1 AR074290"],"award-info":[{"award-number":["RO1 AR074290"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.joca.2022.07.013","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T11:23:25Z","timestamp":1668857005000},"page":"279-290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Does gabapentin provide benefit for patients with knee OA? A benefit-harm and cost-effectiveness analysis"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1605-1465","authenticated-orcid":false,"given":"G.P.","family":"Bensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.C.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.P.","family":"Leifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.R.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Neogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4525-2773","authenticated-orcid":false,"given":"A.M.","family":"Kostic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.D.","family":"Paltiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8413-007X","authenticated-orcid":false,"given":"J.E.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3197-752X","authenticated-orcid":false,"given":"D.J.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.N.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3424-0892","authenticated-orcid":false,"given":"E.","family":"Losina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joca.2022.07.013_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/acr.22412","article-title":"Lifetime medical costs of knee osteoarthritis management in the United States: impact of extending indications for total knee arthroplasty","volume":"67","author":"Losina","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.joca.2022.07.013_bib2","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/acr.22897","article-title":"Number of persons with symptomatic knee osteoarthritis in the US: impact of race and ethnicity, age, sex, and obesity","volume":"68","author":"Deshpande","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.joca.2022.07.013_bib3","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.joca.2013.03.018","article-title":"The epidemiology and impact of pain in osteoarthritis","volume":"21","author":"Neogi","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2022.07.013_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/acr.24131","article-title":"2019 American college of rheumatology\/arthritis foundation guideline for the management of osteoarthritis of the hand, hip, and knee","volume":"72","author":"Kolasinski","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.joca.2022.07.013_bib5","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","article-title":"Central sensitization: implications for the diagnosis and treatment of pain","volume":"152","author":"Woolf","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.joca.2022.07.013_bib6","doi-asserted-by":"crossref","first-page":"iv43","DOI":"10.1093\/rheumatology\/kex419","article-title":"Osteoarthritis: the genesis of pain","volume":"57","author":"Fu","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.joca.2022.07.013_bib7","first-page":"1329","article-title":"Preoperative neuropathic pain-like symptoms and central pain mechanisms in knee osteoarthritis predicts poor outcome 6 Months after total knee replacement surgery","volume":"19","author":"Kurien","year":"2018","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.joca.2022.07.013_bib8","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.joca.2011.03.007","article-title":"Neuropathic pain symptoms in a community knee OA cohort","volume":"19","author":"Hochman","year":"2011","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2022.07.013_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225836","article-title":"Central sensitization in knee osteoarthritis and fibromyalgia: beyond depression and anxiety","volume":"14","author":"L\u00f3pez-Ruiz","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.joca.2022.07.013_bib10","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.joca.2021.03.021","article-title":"Systematic review and meta-analysis of the prevalence of neuropathic-like pain and\/or pain sensitization in people with knee and hip osteoarthritis","volume":"29","author":"Zolio","year":"2021","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2022.07.013_bib11","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.joca.2013.06.023","article-title":"Neuropathic pain symptoms on the modified painDETECT correlate with signs of central sensitization in knee osteoarthritis","volume":"21","author":"Hochman","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2022.07.013_bib12","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/S0140-6736(21)00392-5","article-title":"Nociplastic pain: towards an understanding of prevalent pain conditions","volume":"397","author":"Fitzcharles","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.joca.2022.07.013_bib13","unstructured":"IASP Terminology. vol. 2021: International Association for the Study of Pain 2017."},{"key":"10.1016\/j.joca.2022.07.013_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001326","article-title":"Part of pain labelled neuropathic in rheumatic disease might be rather nociplastic","volume":"6","author":"Bailly","year":"2020","journal-title":"RMD Open"},{"key":"10.1016\/j.joca.2022.07.013_bib15","first-page":"Cd010902","article-title":"Oral nonsteroidal anti-inflammatory drugs for neuropathic pain","volume":"2015","author":"Moore","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.joca.2022.07.013_bib16","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.joca.2016.12.013","article-title":"The association of pre-operative body pain diagram scores with pain outcomes following total knee arthroplasty","volume":"25","author":"Dave","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2022.07.013_bib17","article-title":"Intra-articular analgesia and steroid reduce pain sensitivity in knee OA patients: an interventional cohort study","volume":"2014","author":"J\u00f8rgensen","year":"2014","journal-title":"Pain Res Treat"},{"key":"10.1016\/j.joca.2022.07.013_bib18","first-page":"Cd007938","article-title":"Gabapentin for chronic neuropathic pain in adults","volume":"6","author":"Wiffen","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.joca.2022.07.013_bib19","first-page":"1505","article-title":"Clinical efficacy and tolerability of Gabapentinoids with current prescription patterns in patients with Neuropathic pain","volume":"35","author":"Shaheen","year":"2019","journal-title":"Pakistan J Med Sci"},{"key":"10.1016\/j.joca.2022.07.013_bib20","doi-asserted-by":"crossref","first-page":"l2147","DOI":"10.1136\/bmj.l2147","article-title":"Associations between gabapentinoids and suicidal behaviour, unintentional overdoses, injuries, road traffic incidents, and violent crime: population based cohort study in Sweden","volume":"365","author":"Molero","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.joca.2022.07.013_bib21","unstructured":"Full Prescribing Information: Neurontin (gabapentin). vol. 4168942: US Food and Drug Administration 2017."},{"key":"10.1016\/j.joca.2022.07.013_bib22","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.sapharm.2018.06.018","article-title":"Reports of gabapentin and pregabalin abuse, misuse, dependence, or overdose: an analysis of the food and drug administration adverse events reporting system (FAERS)","volume":"15","author":"Evoy","year":"2019","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.joca.2022.07.013_bib23","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.joca.2015.02.163","article-title":"Pain sensitization in people with knee osteoarthritis: a systematic review and meta-analysis","volume":"23","author":"Fingleton","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2022.07.013_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3344\/kjp.2020.33.1.3","article-title":"Pregabalin and gabapentin in neuropathic pain management after spinal cord injury: a systematic review and meta-analysis","volume":"33","author":"Davari","year":"2020","journal-title":"Korean J Pain"},{"key":"10.1016\/j.joca.2022.07.013_bib25","article-title":"Trends, patient and prescriber characteristics in gabapentinoid use in a sample of United States ambulatory care visits from 2003 to 2016","volume":"9","author":"Zhou","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.joca.2022.07.013_bib26","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.joca.2019.06.008","article-title":"Trends in gabapentinoid prescribing in patients with osteoarthritis: a United Kingdom national cohort study in primary care","volume":"27","author":"Appleyard","year":"2019","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2022.07.013_bib27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.7326\/0003-4819-154-4-201102150-00001","article-title":"Impact of obesity and knee osteoarthritis on morbidity and mortality in older Americans","volume":"154","author":"Losina","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.joca.2022.07.013_bib28","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.joca.2022.07.013_bib29","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold","volume":"371","author":"Neumann","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.joca.2022.07.013_bib30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/0272989X08323299","article-title":"A\u00a0multiattribute model for evaluating the benefit-risk profiles of treatment alternatives","volume":"29","author":"Felli","year":"2009","journal-title":"Med Decis Making"},{"key":"10.1016\/j.joca.2022.07.013_bib31","article-title":"Societal cost of opioid use in symptomatic knee osteoarthritis patients in the United States","author":"Huizinga","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.joca.2022.07.013_bib32","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa052771","article-title":"Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis","volume":"354","author":"Clegg","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.joca.2022.07.013_bib33","unstructured":"National Health and Nutrition Examination Survey (NHANES). Online: Centers for Disease Control and Prevention 2017-2018."},{"key":"10.1016\/j.joca.2022.07.013_bib34","unstructured":"Medicare Current Beneficiaries Survey (MCBS). Centers for Medicare and Medicaid Services 2014-2016."},{"key":"10.1016\/j.joca.2022.07.013_bib35","series-title":"Evaluation of the CMS-HCC Risk Adjustment Model","author":"Pope","year":"2011"},{"key":"10.1016\/j.joca.2022.07.013_bib36","series-title":"Osteoarthritis Initiative","year":"2013"},{"key":"10.1016\/j.joca.2022.07.013_bib37","article-title":"Validation of pain severity assessment using the PainDETECT questionnaire","volume":"03","author":"Sumitani","year":"2017","journal-title":"Int J Anesthesiol Pain Med"},{"key":"10.1016\/j.joca.2022.07.013_bib38","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/rheumatology\/39.10.1095","article-title":"The long-term effects of non-steroidal anti-inflammatory drugs in osteoarthritis of the knee: a randomized placebo-controlled trial","volume":"39","author":"Scott","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.joca.2022.07.013_bib39","unstructured":"Red Book Online. vol. vol. 2020: Truven Health Analytics Inc."},{"key":"10.1016\/j.joca.2022.07.013_bib40","series-title":"The Cost of Dispensing Study: an independent comparative analysis of U.S. prescription dispensing costs","first-page":"1","year":"2015"},{"key":"10.1016\/j.joca.2022.07.013_bib41","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1007\/s10067-019-04573-7","article-title":"Efficacy of duloxetine and gabapentin in pain reduction in patients with knee osteoarthritis","volume":"38","author":"Enteshari-Moghaddam","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.joca.2022.07.013_bib42","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1016\/j.arthro.2020.07.027","article-title":"The cost-effectiveness of platelet-rich plasma compared with hyaluronic acid injections for the treatment of knee osteoarthritis","volume":"36","author":"Samuelson","year":"2020","journal-title":"Arthroscopy"},{"key":"10.1016\/j.joca.2022.07.013_bib43","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/j.clinthera.2006.11.017","article-title":"Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective","volume":"28","author":"Tarride","year":"2006","journal-title":"Clin Therapeut"},{"key":"10.1016\/j.joca.2022.07.013_bib44","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2377-13-56","article-title":"Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting","volume":"13","author":"Athanasakis","year":"2013","journal-title":"BMC Neurol"},{"key":"10.1016\/j.joca.2022.07.013_bib45","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2165\/0019053-200826120-00007","article-title":"A\u00a0cost-utility comparison of four first-line medications in painful diabetic neuropathy","volume":"26","author":"O'Connor","year":"2008","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.joca.2022.07.013_bib46","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/j.pain.0000000000000350","article-title":"Long-term cost-effectiveness of initiating treatment for painful diabetic neuropathy with pregabalin, duloxetine, gabapentin, or desipramine","volume":"157","author":"Bellows","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.joca.2022.07.013_bib47","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.joca.2020.10.001","article-title":"Cost-effectiveness of duloxetine for knee OA subjects: the\u00a0role of pain severity","volume":"29","author":"Sullivan","year":"2021","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2022.07.013_bib48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.joca.2021.09.011","article-title":"Quantitative sensory testing: identifying pain characteristics in patients with osteoarthritis","volume":"30","author":"Arant","year":"2021","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2022.07.013_bib49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.36076\/ppj.2011\/14\/145","article-title":"A\u00a0comprehensive review of opioid-induced hyperalgesia","volume":"14","author":"Lee","year":"2011","journal-title":"Pain Physician"},{"key":"10.1016\/j.joca.2022.07.013_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ocarto.2020.100084","article-title":"Cost-effectiveness of dental antibiotic prophylaxis in total knee arthroplasty recipients with type II diabetes mellitus","volume":"2","author":"Stanley","year":"2020","journal-title":"Osteoarthritis Cartilage Open"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458422009268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458422009268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T04:00:06Z","timestamp":1761019206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458422009268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1063458422009268"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2022.07.013","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does gabapentin provide benefit for patients with knee OA? A benefit-harm and cost-effectiveness analysis","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2022.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Osteoarthritis Research Society International. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}